ClinicalTrials.govpublic full text
Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)
multiple sclerosis, safety, therapeutics, mesenchymal stem cells, multipotent mesenchymal stromal cells, optic neuritis, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 889429
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.